These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20674839)

  • 1. Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control.
    Bracho G; Varela E; Fernández R; Ordaz B; Marzoa N; Menéndez J; García L; Gilling E; Leyva R; Rufín R; de la Torre R; Solis RL; Batista N; Borrero R; Campa C
    Homeopathy; 2010 Jul; 99(3):156-66. PubMed ID: 20674839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis against Leptospirosis using a nosode: can this large cohort study serve as a model for future replications?
    Roniger H; Jacobs J
    Homeopathy; 2010 Jul; 99(3):153-5. PubMed ID: 20674838
    [No Abstract]   [Full Text] [Related]  

  • 3. Leptospirosis prevalence in Chinese populations in the last two decades.
    Zhang C; Wang H; Yan J
    Microbes Infect; 2012 Apr; 14(4):317-23. PubMed ID: 22155621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptospira and leptospirosis in China.
    Hu W; Lin X; Yan J
    Curr Opin Infect Dis; 2014 Oct; 27(5):432-6. PubMed ID: 25061933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory advances in serologic diagnosis and research of human leptospirosis in Cuba].
    Obregón AM; Fernández C; Rodríguez I; Rodríguez J; Zamora Y
    Rev Cubana Med Trop; 2007; 59(1):63-7. PubMed ID: 23427422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-cell inactivated leptospirosis vaccine: future prospects.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2013 Apr; 9(4):763-5. PubMed ID: 23295984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A discussion on setting up target age group for immunization against leptospirosis].
    Zhuo JT; Wang SS; Lan WL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug; 16(4):228-30. PubMed ID: 7585904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protection among unrelated leptospira pathogens serovars: an unfinished story.
    Rosario LA; Arencibia DF; Suarez YE; Infante JF; Valdés BY; Batista N
    Adv Clin Exp Med; 2012; 21(5):581-9. PubMed ID: 23356194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leptospirosis--current problems].
    Wasiński B
    Przegl Epidemiol; 2011; 65(3):471-6. PubMed ID: 22184951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in leptospirosis epidemiology in France. Sixty-six years of passive serological surveillance from 1920 to 2003.
    Baranton G; Postic D
    Int J Infect Dis; 2006 Mar; 10(2):162-70. PubMed ID: 16298537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinico-epidemiological study of leptospirosis in adults in the province of Ciego de Avila].
    Suárez Hernández M; Santisteban Mota R; Cabrera Cabrera J; del Risco Alard ; Pelaéz Martínez R
    Rev Clin Esp; 1995 Jul; 195(7):459-62. PubMed ID: 7667520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leptospirosis. Serological study of an epidemic outbrake in the province of Camagüey].
    Ginebra González O
    Rev Cubana Med Trop; 1976; 28(1):33-8. PubMed ID: 802792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leptospirosis outbreaks in the Ul'ianovsk region].
    Nafeev AA
    Med Parazitol (Mosk); 2003; (3):49-50. PubMed ID: 14564847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new tetravalent canine leptospirosis vaccine provides at least 12 months immunity against infection.
    Klaasen HL; van der Veen M; Sutton D; Molkenboer MJ
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):26-9. PubMed ID: 24054091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of Leptospira serogroups in dogs from Berlin, Germany.
    Mayer-Scholl A; Luge E; Draeger A; Nöckler K; Kohn B
    Vector Borne Zoonotic Dis; 2013 Mar; 13(3):200-2. PubMed ID: 23428087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic infection and risk factors for leptospirosis in Nicaragua.
    Ashford DA; Kaiser RM; Spiegel RA; Perkins BA; Weyant RS; Bragg SL; Plikaytis B; Jarquin C; De Lose Reyes JO; Amador JJ
    Am J Trop Med Hyg; 2000; 63(5-6):249-54. PubMed ID: 11421372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and prevention of leptospirosis in dogs].
    Bergmann M; Llewellyn JR; Hartmann K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2017 Jun; 45(3):163-168. PubMed ID: 28466955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of leptospirosis in New Caledonia: diagnosis issues and burden of disease.
    Goarant C; Laumond-Barny S; Perez J; Vernel-Pauillac F; Chanteau S; Guigon A
    Trop Med Int Health; 2009 Aug; 14(8):926-9. PubMed ID: 19552660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the effectiveness of a new vaccine against human leptospirosis in groups at risk].
    Martínez Sánchez R; Pérez Sierra A; Baró Suárez M; Alvarez AM; Menéndez Hernández J; Díaz González M; Cruz de la Paz R; de los Reyes G; Montoya Batista B; Sierra González G; Armesto del Río M; Saltarén Cobas A; Sabournin Ramos O
    Rev Panam Salud Publica; 2000 Dec; 8(6):385-92. PubMed ID: 11209251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outbreak of human leptospirosis in Guantánamo Province].
    Berdasquera Corcho D; Rodríguez González I; Obregón AM; Fernández Molina C; Segura Prevost R; Bustabad Arigas Ede L; Sánchez Falcón CM
    Rev Cubana Med Trop; 2007; 59(1):24-9. PubMed ID: 23427414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.